565 related articles for article (PubMed ID: 17309576)
21. Comparison of three chronic dialysis models.
Peng WX; Guo QY; Liu SM; Liu CZ; Lindholm B; Wang T
Adv Perit Dial; 2000; 16():51-4. PubMed ID: 11045261
[TBL] [Abstract][Full Text] [Related]
22. Peritoneal dialysis fluid-induced changes of the peritoneal membrane are reversible after peritoneal rest in rats.
Zareie M; Keuning ED; ter Wee PM; Beelen RH; van den Born J
Nephrol Dial Transplant; 2005 Jan; 20(1):189-93. PubMed ID: 15572385
[TBL] [Abstract][Full Text] [Related]
23. Oral supplementation with sulodexide inhibits neo-angiogenesis in a rat model of peritoneal perfusion.
Pletinck A; Van Landschoot M; Steppan S; Laukens D; Passlick-Deetjen J; Vanholder R; Van Biesen W
Nephrol Dial Transplant; 2012 Feb; 27(2):548-56. PubMed ID: 21750165
[TBL] [Abstract][Full Text] [Related]
24. [Comparision of several different peritoneal fibrosis rat models].
Zhuo L; Liu FY; Peng YM; Liu YH; Liu H; Zhou LH; Xu XQ; Jiang JH
Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2005 Apr; 30(2):162-6. PubMed ID: 15898425
[TBL] [Abstract][Full Text] [Related]
25. Long-term effects of glycylglycine peritoneal dialysis solution with neutral pH on peritoneum in rats.
Wieczorowska-Tobis K; Korybalska K; Polubińska A; Radkowski M; Breborowicz A; Montagne A; Oreopoulos DG
Adv Perit Dial; 1997; 13():42-6. PubMed ID: 9360649
[TBL] [Abstract][Full Text] [Related]
26. A comparison of the biocompatibility of phosphate-buffered saline and dianeal 3.86% in the rat model of peritoneal dialysis.
Wieczorowska-Tobis K; Polubinska A; Breborowicz A; Oreopoulos DG
Adv Perit Dial; 2001; 17():42-6. PubMed ID: 11510294
[TBL] [Abstract][Full Text] [Related]
27. Amphotericin B does not increase peritoneal fluid removal.
Wang T; Heimbürger O; Cheng HH; Bergström J; Lindholm B
Adv Perit Dial; 1998; 14():3-10. PubMed ID: 10649681
[TBL] [Abstract][Full Text] [Related]
28. [The role of TGF-beta1/Smads in the development of peritoneal fibrosis induced by high glucose peritoneal dialysate and LPS].
Dou XR; Yu XQ; Li XY; Chen WF; Hao WK; Jia ZJ; Peng WX; Wang X; Yin PD; Wang WJ; Zheng ZH
Zhonghua Yi Xue Za Zhi; 2005 Sep; 85(37):2613-8. PubMed ID: 16321321
[TBL] [Abstract][Full Text] [Related]
29. [High glucose dialysate enhances peritoneal fibrosis through upregulating glucose transporters GLUT1 and SGLT1].
Hong M; Nie Z; Chen Z; Yu X; Bao B
Zhejiang Da Xue Xue Bao Yi Xue Ban; 2016 May; 45(6):598-606. PubMed ID: 28247603
[TBL] [Abstract][Full Text] [Related]
30. Immunopathological changes in a uraemic rat model for peritoneal dialysis.
Zareie M; De Vriese AS; Hekking LH; ter Wee PM; Schalkwijk CG; Driesprong BA; Schadee-Eestermans IL; Beelen RH; Lameire N; van den Born J
Nephrol Dial Transplant; 2005 Jul; 20(7):1350-61. PubMed ID: 15840671
[TBL] [Abstract][Full Text] [Related]
31. Transient overexpression of TGF-{beta}1 induces epithelial mesenchymal transition in the rodent peritoneum.
Margetts PJ; Bonniaud P; Liu L; Hoff CM; Holmes CJ; West-Mays JA; Kelly MM
J Am Soc Nephrol; 2005 Feb; 16(2):425-36. PubMed ID: 15590759
[TBL] [Abstract][Full Text] [Related]
32. Persistent transforming growth factor beta 1 expression may predict peritoneal fibrosis in CAPD patients with frequent peritonitis occurrence.
Lin CY; Chen WP; Fu LW; Yang LY; Huang TP
Adv Perit Dial; 1997; 13():64-71. PubMed ID: 9360653
[TBL] [Abstract][Full Text] [Related]
33. Impact of rapamycin on peritoneal fibrosis and transport function.
Xu T; Xie JY; Wang WM; Ren H; Chen N
Blood Purif; 2012; 34(1):48-57. PubMed ID: 22922738
[TBL] [Abstract][Full Text] [Related]
34. Beneficial effects of aminoguanidine on peritoneal microcirculation and tissue remodelling in a rat model of PD.
Zareie M; Tangelder GJ; ter Wee PM; Hekking LH; van Lambalgen AA; Keuning ED; Schadee-Eestermans IL; Schalkwijk CG; Beelen RH; van den Born J
Nephrol Dial Transplant; 2005 Dec; 20(12):2783-92. PubMed ID: 16204296
[TBL] [Abstract][Full Text] [Related]
35. Effects of peritoneal dialysis solutions on the secretion of growth factors and extracellular matrix proteins by human peritoneal mesothelial cells.
Ha H; Cha MK; Choi HN; Lee HB
Perit Dial Int; 2002; 22(2):171-7. PubMed ID: 11990400
[TBL] [Abstract][Full Text] [Related]
36. Benefits of switching from a conventional to a low-GDP bicarbonate/lactate-buffered dialysis solution in a rat model.
Mortier S; Faict D; Lameire NH; De Vriese AS
Kidney Int; 2005 Apr; 67(4):1559-65. PubMed ID: 15780112
[TBL] [Abstract][Full Text] [Related]
37. Aliskiren ameliorates chlorhexidine digluconate-induced peritoneal fibrosis in rats.
Ke CY; Lee CC; Lee CJ; Subeq YM; Lee RP; Hsu BG
Eur J Clin Invest; 2010 Apr; 40(4):301-9. PubMed ID: 20486991
[TBL] [Abstract][Full Text] [Related]
38. Peritoneal dialysis fluid bioincompatibility and new vessel formation promote leukocyte-endothelium interactions in a chronic rat model for peritoneal dialysis.
Schilte MN; Fabbrini P; Wee PM; Keuning ED; Zareie M; Tangelder GJ; Van Lambalgen AA; Beelen RH; Van Den Born J
Microcirculation; 2010 May; 17(4):271-80. PubMed ID: 20536740
[TBL] [Abstract][Full Text] [Related]
39. Glucocorticoid protects against the development of encapsulating peritoneal sclerosis on peritoneal dialysis.
Imai H; Nakamoto H; Fucshima R; Yamanouchi Y; Ishida Y; Suzuki H
Adv Perit Dial; 2002; 18():124-30. PubMed ID: 12402603
[TBL] [Abstract][Full Text] [Related]
40. Effects of bicarbonate/lactate dialysis solution on the inflammatory response of spontaneous peritonitis in rats undergoing chronic peritoneal dialysis.
Pawlaczyk K; Holmes CJ; Czekalski S; Breborowicz A; Lindholm B
Blood Purif; 2009; 28(3):200-8. PubMed ID: 19648739
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]